Center-Authored Papers

Filters: Author is Rowley, Scott D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2009
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
2011
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.
2012
Martin PJ, Furlong T, Rowley SD, Pergam SA, Lloid M, Schubert MM, Horgan KJ, Storer BE.  2012.  Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(6):922-929. Abstract
2013
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H et al..  2013.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. The New England journal of medicine. 369(13):1227-36. Abstract
Administration, Oral
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H et al..  2013.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. The New England journal of medicine. 369(13):1227-36. Abstract
Adult
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S et al..  2012.  Peripheral-blood stem cells versus bone marrow from unrelated donors.. The New England journal of medicine. 367(16):1487-96. Abstract
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H et al..  2013.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. The New England journal of medicine. 369(13):1227-36. Abstract
Antiviral Agents
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H et al..  2013.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. The New England journal of medicine. 369(13):1227-36. Abstract
Bone Marrow Diseases
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S et al..  2012.  Peripheral-blood stem cells versus bone marrow from unrelated donors.. The New England journal of medicine. 367(16):1487-96. Abstract
Bone Marrow Transplantation
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S et al..  2012.  Peripheral-blood stem cells versus bone marrow from unrelated donors.. The New England journal of medicine. 367(16):1487-96. Abstract
Cause of Death
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S et al..  2012.  Peripheral-blood stem cells versus bone marrow from unrelated donors.. The New England journal of medicine. 367(16):1487-96. Abstract
Center-Authored Paper
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H et al..  2013.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. The New England journal of medicine. 369(13):1227-36. Abstract
Martin PJ, Furlong T, Rowley SD, Pergam SA, Lloid M, Schubert MM, Horgan KJ, Storer BE.  2012.  Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(6):922-929. Abstract
Chronic Disease
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Clinical Research Division
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers MED, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT et al..  2011.  Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(1):124-32. Abstract
Martin PJ, Furlong T, Rowley SD, Pergam SA, Lloid M, Schubert MM, Horgan KJ, Storer BE.  2012.  Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(6):922-929. Abstract
Martin PJ, Storer BE, Rowley SD, Flowers MED, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M et al..  2009.  Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.. Blood. 113(21):5074-82. Abstract
Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S et al..  2012.  Peripheral-blood stem cells versus bone marrow from unrelated donors.. The New England journal of medicine. 367(16):1487-96. Abstract
Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, Brundage TM, Robertson AT, Godkin S, Momméja-Marin H et al..  2013.  CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. The New England journal of medicine. 369(13):1227-36. Abstract
Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.